Skip to content

To study the effect of intrauterine Platelet Rich Plasma therapy on pregnancy rates in unexplained infertility

Effect of autologous intrauterine Platelet Rich Plasma therapy on endometrial receptivity and clinical pregnancy rate in unexplained infertility

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061002
Enrollment
130
Registered
2024-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

Intervention1: Platelet rich plasma: Autologous intrauterine instillation of platelet rich plasma after 2 days of intrauterine insemination in case cycle Control Intervention1: Nil: nil

Sponsors

University College of Medical Sciences and Guru Teg Bahadur Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Diagnosed case of Unexplained infertility (documented ovulation, at least unilateral tubal patency, normal uterine cavity and normal semen analysis). - BMI: 19-25 Kg/m2

Exclusion criteria

Exclusion criteria: a) Patient on any hormonal therapy or NSAID b) Female with the diagnosis of hematological disorder and autoimmune disorder. c) Females with chronic medical disorder such as diabetes, hypertension and tuberculosis. d) Presence of active infection such Pelvic inflammatory diseases, vaginal or cervical infection

Design outcomes

Primary

MeasureTime frame
a) Comparison of Clinical pregnancy rate with and without PRP therapy in IUI in unexplained infertility. b) Comparison of endometrial receptivity with and without PRP therapy in IUI in unexplained infertility.Timepoint: a) 15 days after IUI – UPT will be done b) 10-15 days after missed period- TVS for cardiac activity or gestational sac will be done to confirm clinical pregnancy c) Endometrial receptivity scoring will be done on the day of IUI, 2 days after IUI, and 4 days after IUI

Secondary

MeasureTime frame
a) Comparison of luteal phase S. EGF levels with or without PRP therapy in unexplained infertility b) Correlation of endometrial receptivity with clinical pregnancy rates c) Side effects of PRP therapy in the studyTimepoint: Serum EGF levels after 4 days of IUI

Countries

India

Contacts

Public ContactArchee Sinha

UCMS and GTB Hospital

dralpanasingh@gmail.com7042109290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026